About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Current Opinion in Therapeutic Patents
›
top-articles
Current Opinion in Therapeutic Patents
0.0
(top 100%)
impact factor
692
(top 20%)
papers
353
(top 50%)
citations
7
(top 50%)
h
-index
0.1
(top 100%)
extended IF
860
all documents
360
doc citations
14
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Overview: PAF Receptor Antagonists: Recent Advances
Current Opinion in Therapeutic Patents
1992
24
2
Patent Update: ACAT Inhibitors
Current Opinion in Therapeutic Patents
1993
20
3
Patent Update: Inhibitors of the Phospholipases A2
Current Opinion in Therapeutic Patents
1993
15
4
Overview: Structure-Activity Relationships of Prostaglandin Analogues as Ocular Hypotensive Agents
Current Opinion in Therapeutic Patents
1993
13
5
Overview: Macrolide Immunosuppressants
Current Opinion in Therapeutic Patents
1993
10
6
Patent Update: Phospholipase A2Inhibitors
Current Opinion in Therapeutic Patents
1992
7
7
Overview: Recent Developments in Anxiolytics
Current Opinion in Therapeutic Patents
1993
7
8
Overview: Recent Advances in Angiotensin II Receptor Antagonists
Current Opinion in Therapeutic Patents
1993
7
9
Overview: Agonists, Antagonists and Modulators of the N-methyl-D-aspartic acid (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) Subtypes of Glutamate Receptors
Current Opinion in Therapeutic Patents
1993
6
10
Anti-infectives Overview: The development of potential anti-influenza drugs
Current Opinion in Therapeutic Patents
1993
6
11
Overview: Diabetes: New Chemical Entities
Current Opinion in Therapeutic Patents
1992
5
12
Patent Update: Small Molecule Immunomodulators
Current Opinion in Therapeutic Patents
1992
5
13
Overview: Excitatory Amino Acid Antagonists
Current Opinion in Therapeutic Patents
1992
5
14
Overview: Dual-Action β-Lactam Antibacterials
Current Opinion in Therapeutic Patents
1992
5
15
Overview: Recent Advances in Organic Nitrates
Current Opinion in Therapeutic Patents
1993
5
16
Overview: Retroviral Vectors for Gene Therapy and Transgenics
Current Opinion in Therapeutic Patents
1993
5
17
Patent Update: Renin Angiotensin System: Recent Advances in Inhibitor Design
Current Opinion in Therapeutic Patents
1993
5
18
Overview: Therapeutic Uses of Cell-Matrix Adhesive Proteins
Current Opinion in Therapeutic Patents
1993
5
19
Patent Evaluation: Novel inhibitors of atherosclerotic intimal thickening
Current Opinion in Therapeutic Patents
1993
5
20
Overview: Challenges in the Search for CNS Therapeutics in the 1990's
Current Opinion in Therapeutic Patents
1991
4
21
Overview: Recent Advances in Elastase Inhibitors
Current Opinion in Therapeutic Patents
1992
4
22
Overview: Oncologic, Endocrine & Metabolic Antisense oligonucleotides for the treatment of cancer
Current Opinion in Therapeutic Patents
1993
4
23
Overview: Potent GABA
B
Agonists and Antagonists
Current Opinion in Therapeutic Patents
1993
4
24
Overview: Recent Developments in Sulphidopeptide Leukotriene Receptor Antagonists
Current Opinion in Therapeutic Patents
1992
3
25
Overview: Excitatory Amino Acids;Current Opinion in Therapeutic Patents June 1992
Current Opinion in Therapeutic Patents
1992
3
26
Patent Update: Neurokinin Receptor Antagonists
Current Opinion in Therapeutic Patents
1993
3
27
Patent News: Platelet-Activating Factor Receptor Antagonists
Current Opinion in Therapeutic Patents
1993
3
28
Overview: Virally Based Transient Expression Systems
Current Opinion in Therapeutic Patents
1993
3
29
Patent Update: Antibacterial Patent Activity: October 1992 to March 1993
Current Opinion in Therapeutic Patents
1993
3
30
Patent Update: Lipoxygenase Inhibitors and Leukotriene Antagonists as Therapeutic Agents
Current Opinion in Therapeutic Patents
1991
2
31
Patent Update: Cholinergic Agents: Recent Advances December 1991 through June 1992
Current Opinion in Therapeutic Patents
1992
2
32
Overview: New Antipsychotic Agents: A Patent Overview — 1991
Current Opinion in Therapeutic Patents
1992
2
33
Patent Update: Potential Therapeutic Agents for the Treatment of Allergic and Gastrointestinal Disorders
Current Opinion in Therapeutic Patents
1992
2
34
Patent Update: Agents for the Treatment of Neurodegenerative Diseases: Recent Advances, January Through June, 1992
Current Opinion in Therapeutic Patents
1992
2
35
Patent Update: Antifungal Agents - Recent Patent Activity
Current Opinion in Therapeutic Patents
1992
2
36
Overview: Recent Developments in Antifilarial Agents
Current Opinion in Therapeutic Patents
1992
2
37
Overview: Inhibitors of Bone Resorption and Implications for Therapy
Current Opinion in Therapeutic Patents
1992
2
38
Patent Evaluation: Growth Inhibition by Oligonucleotides
Current Opinion in Therapeutic Patents
1992
2
39
Patent Update: Serotonergic Agents: June-December 1991
Current Opinion in Therapeutic Patents
1992
2
40
Overview: Strategies for the Prevention of Graft Rejection
Current Opinion in Therapeutic Patents
1992
2
41
Patent Update: Cerebral Anti-lschaemic Agents: Recent Advances, June Through December, 1991
Current Opinion in Therapeutic Patents
1992
2
42
Patent Update: Inhibitors of Tyrosine Kinase Activity as Anticancer Therapeutics: Recent Developments
Current Opinion in Therapeutic Patents
1993
2
43
Overview: Biotinylated Monoclonal Antibodies: Their Potential for Diagnosis and Therapy of Cancer
Current Opinion in Therapeutic Patents
1993
2
44
Patent Update: Anti-inflammatory Patent Highlights from the Second Half of 1992
Current Opinion in Therapeutic Patents
1993
2
45
April CNS Patent Distribution
Current Opinion in Therapeutic Patents
1991
1
46
Overview: Novel Analogues of Mineralocorticoids, Antimineralocorticoids and Related Compounds
Current Opinion in Therapeutic Patents
1991
1
47
Overview: Recent Aspects of Transgene Technology
Current Opinion in Therapeutic Patents
1991
1
48
Patent Update: Adhesion Molecules: Mediators of Inflammation and the Immune System
Current Opinion in Therapeutic Patents
1991
1
49
Anti-allergic, antihistamine/H1-antagonist: 1-Alkoxyalkyl-2-alkylthiobenzimidazoles as Highly Potent Antihistamines
Current Opinion in Therapeutic Patents
1991
1
50
Patent Evaluation: Detection and Modulation of Gene Expression by Oligonucleotides
Current Opinion in Therapeutic Patents
1992
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.